Ceftriaxone
Back to searchMolecule Structure
Scientific Name
Ceftriaxone
Description of the Drug
Ceftriaxone is a broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, such as in the respiratory tract, skin, soft tissue, and urinary tract.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01212
http://www.drugbank.ca/drugs/DB01212
Brand Name(s)
Not Available
Company Owner(s)
Hikma Farmaceutica (Portugal) Sa, Agila Specialties Private Ltd, Fresenius Kabi Usa Llc, Samson Medical Technologies Llc, Lupin Ltd, Facta Farmaceutici Spa, B Braun Medical Inc, Bedford Laboratories Div Ben Venue Laboratories Inc, Sandoz Inc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL23354 | ||||||
| PharmGKB | PA448866 | ||||||
| Human Metabolome Database | HMDB0015343 | ||||||
| WDI | CEFTRIAXO | ||||||
| DrugBank | DB01212 | ||||||
| PubChem: Thomson Pharma | 14935103 | 15968575 | 14886134 | ||||
| PubChem | 5479530 | ||||||
| Nikkaji | J11.973C | ||||||
| BindingDB | 50103601 | ||||||
| EPA CompTox Dashboard | DTXSID0022773 | ||||||
| DrugCentral | 564 | ||||||
| Brenda | 21558 | 48892 | 44279 | 229254 | 3525 | 232628 | 229255 |
| ChemicalBook | CB9114533 | ||||||
| Guide to Pharmacology | 5326 | ||||||
| GSRS | aa6aa6b7-a01c-4617-ae49-b227badaf9b4 | ||||||
| rxnorm | CEFTRIAXONE | CEFTRIAXONE SODIUM | |||||
| KEGG Ligand | C06683 | ||||||
| ChEBI | 29007 | ||||||
| ZINC | ZINC000028467879 |
